Literature DB >> 11689093

Subjective experience after traumatic brain injury.

C Martin1, D Viguier, G Deloche, G Dellatolas.   

Abstract

The present investigation aims to show which specific difficulties are reported with greater frequency in traumatic brain injury (TBI) patients than in controls, and in hetero-assessment than in self-assessment. Ninety-seven patients with severe TBI were compared to 97 controls matched for age and gender. The 63-item European Brain Injury Questionnaire (EBIQ) was completed by patients, close relatives and controls. A principal component analysis showed three main factors: "depressive mood", "cognitive difficulties", and "difficulties in social interactions". Relatives scored higher than patients for items concerning the three domains. Patients scored higher than controls for "depressive mood" and "cognitive difficulties", but not for "difficulties in social interactions", which included items related to both self-assertion and lack of self-control. After TBI, emotional problems and, especially, depressive mood associated to cognitive difficulties have an important impact in everyday life and family functioning. Difficulties in social interactions are not specific of TBI patients.

Entities:  

Mesh:

Year:  2001        PMID: 11689093     DOI: 10.1080/02699050110065655

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  2 in total

1.  A survey of very-long-term outcomes after traumatic brain injury among members of a population-based incident cohort.

Authors:  Allen W Brown; Anne M Moessner; Jay Mandrekar; Nancy N Diehl; Cynthia L Leibson; James F Malec
Journal:  J Neurotrauma       Date:  2011-02-05       Impact factor: 5.269

2.  Development and psychometric properties of the Patient-Head Injury Participation Scale (P-HIPS) and the Patient-Head Injury Neurobehavioral Assessment Scale (P-HINAS): patient and family determined outcomes scales.

Authors:  Shoumitro Deb; Eleanor Bryant; Paul G Morris; Lindsay Prior; Glyn Lewis; Sayeed Haque
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.